Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Compound 7p shows strong potential as an anticancer agent.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

New compounds were made that are promising for prostate cancer therapy.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Nilotinib can cause keratosis pilaris, a skin condition.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Nilotinib can cause generalized keratosis pilaris.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Finasteride helps female-pattern hair loss.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.